Identification of a novel KMT2A-SEPT14 fusion in acute myeloid leukemia

Leuk Lymphoma. 2018 Jan;59(1):265-267. doi: 10.1080/10428194.2017.1324163. Epub 2017 Jun 2.

Authors

Doreen Nguyen¹, Lisa Haley¹, Aparna Pallavajjala¹, Ivana Gojo², Yi Ning¹

Affiliations

¹ a Department of Pathology , Johns Hopkins University School of Medicine , Baltimore , MD , USA.
² b Department of Oncology, Sidney Kimmel Comprehensive Cancer Center , Johns Hopkins University School of Medicine , Baltimore , MD , USA.

PMID: 28573893
DOI: 10.1080/10428194.2017.1324163

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Acute Disease
Aged
Chromosomes, Human, Pair 11 / genetics
Chromosomes, Human, Pair 7 / genetics
High-Throughput Nucleotide Sequencing
Histone-Lysine N-Methyltransferase / genetics*
Humans
In Situ Hybridization, Fluorescence
Karyotyping
Leukemia, Myeloid / genetics*
Leukemia, Myeloid / pathology
Male
Myeloid-Lymphoid Leukemia Protein / genetics*
Oncogene Proteins, Fusion / genetics*
Septins / genetics*
Translocation, Genetic

Substances

KMT2A protein, human
Oncogene Proteins, Fusion
Myeloid-Lymphoid Leukemia Protein
Histone-Lysine N-Methyltransferase
SEPTIN14 protein, human
Septins